PTG-300 reversed iron deficiency and eliminated the need for therapeutic phlebotomy in patients with polycythemia vera. Marina Kremyanskaya, MD, PhD, discusses results from the phase II PTG-300-04 trial.
Advertisement intended for health care professionals
PTG-300 reversed iron deficiency and eliminated the need for therapeutic phlebotomy in patients with polycythemia vera. Marina Kremyanskaya, MD, PhD, discusses results from the phase II PTG-300-04 trial.
Advertisement intended for health care professionals